These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 7472741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
    Viereck V, Siggelkow H, Pannem R, Braulke T, Scharf JG, Kübler B.
    J Cell Biochem; 2007 Sep 01; 102(1):28-40. PubMed ID: 17372931
    [Abstract] [Full Text] [Related]

  • 3. IGF-II receptor number is increased in TE-85 osteosarcoma cells by combined magnetic fields.
    Fitzsimmons RJ, Ryaby JT, Magee FP, Baylink DJ.
    J Bone Miner Res; 1995 May 01; 10(5):812-9. PubMed ID: 7639117
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K, Höflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W.
    J Cell Physiol; 1994 Jun 01; 159(3):531-41. PubMed ID: 8188767
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Growth hormone receptor activity is stimulated by insulin-like growth factor binding protein 5 in rat osteosarcoma cells.
    Slootweg MC, Ohlsson C, van Elk EJ, Netelenbos JC, Andress DL.
    Growth Regul; 1996 Dec 01; 6(4):238-46. PubMed ID: 8971553
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
    Avnet S, Sciacca L, Salerno M, Gancitano G, Cassarino MF, Longhi A, Zakikhani M, Carboni JM, Gottardis M, Giunti A, Pollak M, Vigneri R, Baldini N.
    Cancer Res; 2009 Mar 15; 69(6):2443-52. PubMed ID: 19258511
    [Abstract] [Full Text] [Related]

  • 12. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG, Morgan J, Schwander J, Bleehen NM.
    Cancer Res; 1993 Oct 01; 53(19):4680-5. PubMed ID: 7691401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL, Casinghino S, Centrella M, Canalis E.
    J Cell Physiol; 1994 Jul 01; 160(1):163-75. PubMed ID: 7517403
    [Abstract] [Full Text] [Related]

  • 16. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
    Rutten AA, Bermudez E, Stewart W, Everitt JI, Walker CL.
    Cancer Res; 1995 Aug 15; 55(16):3634-9. PubMed ID: 7627973
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT, Schmid C, Ghirlanda-Keller C, Olie R, Winterhalter KH, Zapf J.
    Exp Cell Res; 2001 Dec 10; 271(2):368-77. PubMed ID: 11716549
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
    Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM.
    Clin Cancer Res; 2003 Jul 10; 9(7):2587-97. PubMed ID: 12855635
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.